Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.18% is in line with its 5-year average of 2.18%, around the middle of its 5-year range (0.41%–4.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.06% above its 12-month average of 2.18%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.18%.
DEBT TO ASSETS RATIO
2.18%
DEBT TO ASSETS RATIO AVG TTM
2.18%
DEBT TO ASSETS RATIO AVG 3Y
2.94%
DEBT TO ASSETS RATIO AVG 5Y
2.18%
DEBT TO ASSETS RATIO AVG 10Y
2.26%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.06%
CURRENT VS 3Y AVG
-25.74%
CURRENT VS 5Y AVG
+0.17%
CURRENT VS 10Y AVG
-3.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+2081.72%
vs the sector median at left
Entera Bio Ltd.
Market Cap
$129.39M
Debt to Assets Ratio
2.18%
TTM Avg
2.18%
3Y Avg
2.94%
5Y Avg
2.18%
Market Cap
$131.16M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$122.26M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.86M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.80M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.80M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.09M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $129.39M | 2.18% | 2.18% | 2.94% | 2.18% |
| Cibus, Inc. (CBUS)vs › | $129.76M | 0.10% | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 0.47% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $135.41M | 0.10% | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | 0.12% | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $136.86M | 0.36% | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 0.12% | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $119.80M | 0.09% | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | 0.01% | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $140.14M | N/A | N/A | N/A | N/A |
Debt/Assets
2.2%
Debt/Equity
0.06
Current Ratio
8.98
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.18% |
| 2026-03-31 | 3.41% |
| 2025-12-31 | 3.06% |
| 2025-09-30 | 1.21% |
| 2025-06-30 | 1.03% |
| 2025-03-31 | 1.02% |
| 2024-12-31 | 2.90% |
| 2024-09-30 | 3.99% |
| 2024-06-30 | 3.33% |
| 2024-03-31 | 3.68% |
| 2023-12-31 | 3.31% |
| 2023-09-30 | 4.69% |
| 2023-06-30 | 4.37% |
| 2023-03-31 | 0.41% |
| 2022-12-31 | 0.69% |
| 2022-09-30 | 0.85% |
| 2022-06-30 | 0.93% |
| 2022-03-31 | 1.08% |
| 2021-12-31 | 1.16% |
| 2021-09-30 | 1.14% |
| 2021-06-30 | 1.28% |
| 2021-03-31 | 2.17% |
| 2020-12-31 | 4.44% |
| 2020-09-30 | 2.46% |
| 2020-06-30 | 2.18% |
| 2020-03-31 | 1.86% |
| 2019-12-31 | 1.79% |
| 2019-09-30 | 4.49% |
| 2019-06-30 | 3.90% |
| 2019-03-31 | 3.29% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 46.78% |
| 2017-12-31 | 29.32% |
| 2017-09-30 | 370.00% |
| 2017-06-30 | 405.90% |
| 2016-12-31 | 234.17% |
